Session » B Cell Biology and Targets in Autoimmune and Inflammatory Disease Poster

Date: Sunday, October 21, 2018

Time: 9:00AM-11:00AM

Meeting: 2018 ACR/ARHP Annual Meeting

9:00AM-11:00AM: Abstract Number: 15

Abnormal ZAP-70 Expression in B Cells: New Potential Role in Tolerance Breakdown

9:00AM-11:00AM: Abstract Number: 4

Anti-Jo1 Positive Myositis Patients Display a Characteristic IgG Fc-Glycan Profile Which Is Further Enhanced in Anti-Jo1 Autoantibodies

9:00AM-11:00AM: Abstract Number: 30

CD21lo Cells Are Increased in Patients with Systemic Sclerosis and May be Associated with Interstitial Lung Disease

9:00AM-11:00AM: Abstract Number: 29

CD70-Mediated CD27 Downregulation Contributed to Regulatory B10 Cell Impairment in Rheumatoid Arthritis

9:00AM-11:00AM: Abstract Number: 25

Circulating CD24hiCD38hi Regulatory B-Cells Influence Th17-Cell Responses in Patients with Granulomatosis with Polyangiitis

9:00AM-11:00AM: Abstract Number: 19

Citrulline-Multispecific B Cell Receptor Clades in Rheumatoid Arthritis

9:00AM-11:00AM: Abstract Number: 16

Comprehensive Antibody Profiling Using High Density Peptide Arrays Reveals Novel Citrullinated Protein Targets in Rheumatoid Arthritis Serum Samples

9:00AM-11:00AM: Abstract Number: 18

Cytoplasmic FOXO1 Identifies Novel Disease-Activity Associated B Cell Subsets in SLE

9:00AM-11:00AM: Abstract Number: 21

Elevated EPSTI1 Promote B Cells Hyperactivation through NF-Kb Signaling in Patients with Sjögren ’s Syndrome

9:00AM-11:00AM: Abstract Number: 20

Expression and Functions of the Transcription Factors Ikaros and Aiolos in Sjogren’s Syndrome and Systemic Lupus Erythematosus

9:00AM-11:00AM: Abstract Number: 10

Fibroblast like Synoviocytes (FLS) Are Capable of Inducing Phenotypical Changes Including Class Switch Recombination (CSR) in Naive B Cells, but Additional Factors Are Required to Trigger Immunoglobulin Secretion

9:00AM-11:00AM: Abstract Number: 26

Hints for Catecholamine-Driven Autocrine Mechanisms to Regulate Regulatory B Cells

9:00AM-11:00AM: Abstract Number: 14

Individual RA-Derived Monoclonal Anti-Citrullinated Protein Autoantibodies (ACPA) Have Extensive Citrulline Multi-Reactivity Demonstrated By a Large-Scale Protein Array Platform

9:00AM-11:00AM: Abstract Number: 9

Integration of Cytokine Profiles with Distinct B-Cell Functions Reveals a Specific Micro-Environmental Framework in Autoimmune Diseases

9:00AM-11:00AM: Abstract Number: 3

Interferon-Alpha Disrupts DNA-Specific B Cell Tolerance in 3H9 Mice

9:00AM-11:00AM: Abstract Number: 17

Kappa-Deleting Recombination Excision Circles (KREC) in B Cells and Serum B Cell Activating Factor (BAFF): Possible Aids in Predicting Juvenile Dermatomyositis Response to Rituximab

9:00AM-11:00AM: Abstract Number: 22

Monoclonal Anti-Citrullinated Protein Antibodies Generated from RA-Derived B Cells Recognize Amino Acid Motifs Rather Than Specific Proteins

9:00AM-11:00AM: Abstract Number: 11

PAD4-Independent Interaction of ACPA with Nuclear Antigens in Apoptotic Cells and Neutrophil Extracellular Traps (NETs) Defines a Subset of Autoantibodies

9:00AM-11:00AM: Abstract Number: 1

Profiling of B-Cell Related Factors and Its Decoy Receptors in Rheumatoid Arthritis: Potential Clues for Patient Stratification

9:00AM-11:00AM: Abstract Number: 12

Protein Phosphatase 2A, a Serine/Threonine Phosphatase, Is Essential for Optimal B Cell Function

9:00AM-11:00AM: Abstract Number: 8

Repertoire Studies in Rheumatoid Arthritis Reveal B-Cell Distortions and Baseline Shifts in Unmutated IgG

9:00AM-11:00AM: Abstract Number: 24

Rituximab Induces an Early Re-Assessment of the Immune and Vascular Systems in Patients with Systemic Lupus Erythematosus and Rheumatoid Arthritis

9:00AM-11:00AM: Abstract Number: 7

RNA Sequencing Detection of Gene Dysregulation in B Cells Sorted from Salivary Gland Tissue and from Peripheral Blood Reveals New Pathways Involved in Primary Sjögren’s Syndrome Pathophysiology

9:00AM-11:00AM: Abstract Number: 6

Ro52/Trim21 Influences Follicular B Cell Homeostasis and Immunoglobulin Production

9:00AM-11:00AM: Abstract Number: 13

Shared Genetic Origins Among Anti-Proteinase 3 and Anti-Glomerular Basement Membrane Double-Positive Human Autoantibodies

9:00AM-11:00AM: Abstract Number: 5

Short Chain Fatty Acid Acetate Induces Regulatory B Cells in Mice and Humans, Which Can Protect Against Arthritis

9:00AM-11:00AM: Abstract Number: 2

The Influence of Abatacept on Human B Cell Functions

9:00AM-11:00AM: Abstract Number: 28

The Rho Kinase Family Member, ROCK2, Promotes Germinal Center Responses and Is Required for Optimal Humoral Immunity

9:00AM-11:00AM: Abstract Number: 27

Top-Down Proteomics Coupled with Antibody Sequencing from Single B Cells Reveals a Monoclonal Anti-Sm Clone Present in the Serum of an SLE Patient over Three Years

9:00AM-11:00AM: Abstract Number: 23

Treatment with Immune Checkpoint Inhibitors and the Development of Autoantibodies

« View all sessions from this meeting

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].